Skip to main content

A minituarized disposable molecular diagnostics platform for combatting coronavirus infections

Project description

Novel diagnostic platform for COVID-19 rapid test

The EU-funded DECISION project is developing a new class of COVID-19 diagnostic platforms and tests in a joint effort by teams from Italy, Spain and Germany. The diagnostic platform will enable the rapid detection of COVID-19 infections on-site in any possible setting, including drive-through testing centres, airports or medical offices. The low-cost, miniature, disposable diagnostic platform is powered by a next-generation nucleic acid amplification technology called pulse controlled amplification (PCA®), providing sample-to-answer workflows in less than 15 minutes. The objective is to deliver the molecular diagnostic platform and coronavirus test within five months after the start of the project.

Coordinator

AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH
Net EU contribution
€ 2 064 178,49
Address
Giefinggasse 4
1210 Wien
Austria
Activity type
Research Organisations
Non-EU contribution
€ 0,00

Participants (4)

MICROLIQUID SL

Participation ended

Spain
Net EU contribution
€ 343 053,24
SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Address
Avenida Uribarri 19-1 Saiolan
20500 Arrasate Mondragon
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 0,00
ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO
Italy
Net EU contribution
€ 406 350,00
Address
Via Portuense, 292
00149 Roma
Activity type
Research Organisations
Non-EU contribution
€ 0,00
BUNDESMINISTERIUM DER VERTEIDIGUNG
Germany
Net EU contribution
€ 425 250,00
Address
Fontainengraben 150
53123 Bonn
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Non-EU contribution
€ 0,00
Region
Nordrhein-Westfalen Köln Bonn, Kreisfreie Stadt
GNA BIOSOLUTIONS GMBH
Germany
Net EU contribution
€ 196 268,27
SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Address
Am Klopferspitz 19
82152 Martinsried
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 312 500,00
Region
Bayern Oberbayern München, Landkreis